Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Patients & Caregivers

Healthcare Professionals - Opens new window

Worldwide - Opens new window

Quick Find - Click to open on a page

Merck Pipeline

The interactive content on Merck.com requires the Adobe Flash Player, which you can download for free here.

The Merck Manuals

NYSE | MRK 37.6800 | +0.7200

4:00 PM ET | 18 Jul 2008

Product News: Read the latest news on Merck medicines and vaccines
Research & Development News: Read the latest news on Merck Research and Development
Corporate News: Merck to Fund U.S. VIOXX® Product Liability Resolution Program
Financial News: Merck to Hold Second-Quarter 2008 Sales and Earnings Conference Call and Webcast on July 21

Public Policy: Merck's position on key public policy issues
SINGULAIR® (montelukast): Statement: FDA early communication on safety review of SINGULAIR
MerckVaccines.com: Direct ordering, account management, and product information
FOSAMAX® (alendronate sodium): Statement regarding Osteonecrosis of the Jaw
VIOXX Information Center: Information on the voluntary withdrawal of VIOXX® (rofecoxib)

This U.S. Web site is subject to Merck.com Terms of Use

RSS